Monografie
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
- Sprache
-
Englisch
- Identifier
-
oai:gesis.izsoz.de:document/54546
1186317701
- DOI
-
10.9789/2175-5361.2014.v6i4.1642-1654
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Ähnliche Objekte (12)
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Mocravimod, a selective S1PR modulator in allogeneic hematopoietic stem cell transplantation for malignancy
Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Mocravimod, a selective S1PR modulator in allogeneic hematopoietic stem cell transplantation for malignancy
Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Mocravimod, a selective S1PR modulator in allogeneic hematopoietic stem cell transplantation for malignancy